Arvinas Inc ARVN:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:03 PM EDT
101.10UNCH (UNCH)
Volume
10,255
Close
101.10quote price arrow down-6.77 (-6.28%)
Volume
723,327
52 week range
19.68 - 108.47

...

Loading . . .
  • Open103.78
  • Day High104.90
  • Day Low99.50
  • Prev Close107.87
  • 52 Week High108.47
  • 52 Week High Date07/29/21
  • 52 Week Low19.68
  • 52 Week Low Date10/28/20

Key Stats

  • Market Cap4.953B
  • Shares Out48.99M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change19.04

KEY STATS

  • Open103.78
  • Day High104.90
  • Day Low99.50
  • Prev Close107.87
  • 52 Week High108.47
  • 52 Week High Date07/29/21
  • 52 Week Low19.68
  • 52 Week Low Date10/28/20
  • Market Cap4.953B
  • Shares Out48.99M
  • 10 Day Average Volume0.85M
  • Dividend-
  • Dividend Yield-
  • Beta2.02
  • YTD % Change19.04

RATIOS/PROFITABILITY

  • EPS (TTM)-3.28
  • P/E (TTM)-30.85
  • Fwd P/E (NTM)-54.18
  • EBITDA (MRQ)-139.395M
  • ROE (MRQ)-33.51%
  • Revenue (MRQ)21.10M
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-656.62%
  • Debt To Equity (MRQ)0.33%

EVENTS

  • Earnings Date08/02/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Arvinas Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Arvinas, Inc., formerly Arvinas Holding Co LLC, is a development staged biopharmaceutical company. The Company is engaged in the development and commercialization of therapies to degrade disease-causing proteins. The Company uses its technology platform to engineer proteolysis targeting chimeras (PROTACs), which are designed to harness the body’s own natural protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. The Company is...
Timothy Shannon M.D.
Non-Executive Chairman
John Houston Ph.D.
President
Sean Cassidy CPA
Chief Financial Officer
Address
5 Science Park
New Haven, CT
06511-1966
United States

Top Peers

SYMBOLLASTCHG%CHG
RETA
Reata Pharmaceuticals Inc
125.31-2.75-2.15%
KOD
Kodiak Sciences Inc
83.84-4.03-4.59%
ALLK
Allakos Inc
79.56-1.94-2.38%
SAVA
Cassava Sciences Inc
69.53-33.82-32.72%
EIDX